Figure 5From: Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in IndonesiaCumulative risk of failure of artemisinin-naphthoquine (AN) versus dihydroartemisinin-piperaquine (DHP) in ITT population infected with any malaria. The TF by day 28 and 42 were 4.5% (9 of 201) and 10% (20 of 201) in AN group, and 7% (14 of 200) and 10% (20 of 200) in DHP group. The hazard ratio of failure between AN and DHP groups was 0.98 (95% CI: 0.53–1.82) with p = 0.95.Back to article page